Skip to content

Clinical trials

Pulmonary Eosinophilia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Eosinophilia Country / region: Poland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20113
20141
20151
20161
20181
20201
20221
20233
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated3
Active, not recruiting2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Areteia Therapeutics3
GlaxoSmithKline3
Teva Branded Pharmaceutical Products R&D, Inc.3
AstraZeneca1
GB001, Inc, a wholly owned subsidiary of Gossamer Bio, Inc.1
Kymera Therapeutics, Inc.1
Medical University of Lodz1
Medical University of Warsaw1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Eosinophilia14
Asthma9
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.